Dr. Patricia Robinson, an oncologist, explains why minority participation is so important in clinical trials.
Dr. Patricia Robinson, an oncologist, explains some of the barriers that keep patients from joining cancer clinical trials.
Dr. Patricia Robinson, an oncologist, explains some of the different kinds of clinical trials and how clinical trial design is changing with targeted therapies.
Mary Clare joined a cancer clinical trial when she was done with treatment to give herself a chance at a longer remission.
Elisa moved from Chile to Chicago to participate in an immunotherapy clinical trial for her metastatic breast cancer.
Wendy joined a clinical trial for her treatment of triple negative breast cancer. She had worked on clinical trial design as a statistician before she was diagnosed.
Glen lives with prostate and Merkel cell cancer. He joined a clinical trial for prostate cancer when he was first diagnosed to give himself a chance at less side effects than the standard treatment.